Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lippia sidoides essential oil gel is an investigational phytopharmaceutical topical preparation containing 10% essential oil extracted from *Lippia sidoides* Cham. (Verbenaceae), a shrub native to Northeastern Brazil commonly known as Alecrim-pimenta. Developed by researchers at the University of Fortaleza (UNIFOR), the gel is intended for the treatment and prevention of dental plaque and gingivitis. The essential oil is characterized by high concentrations of the monoterpenes thymol and carvacrol, which provide potent antimicrobial, anti-inflammatory, and antioxidant properties. In clinical trials, the gel has demonstrated significant reductions in plaque and gingival indices, showing efficacy comparable to the gold-standard antiseptic chlorhexidine, while potentially offering a natural alternative with fewer side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lippia sidoides essential oil gel.